StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / agomab.com

Agomab Therapeutics

Agomab Therapeutics (agomab.com): 3 changes recorded in its website history since August 2020. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeAgomab Therapeutics – Restoring Organ Function
    AfterAgomab Therapeutics – building a company focused on treating fibrosis

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. FundingBetween and

    Announced on its homepage: “Under his leadership, CureVac raised over $1.6 billion in equity.”.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  3. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 23 August 2020

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

agonistic antibodies that regenerate damaged tissues

Homepage

Funding statements on the website
AgomAb Therapeutics Closes Series A Extension Round with Additional Funding from Andera Partners Oct 10, 2019 AgomAb Therapeutics N.V.

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. February 2026 – November 2026 · 6 captures · latest observed messagingAgomab Therapeutics – building a company focused on treating fibrosis

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 6 captures in this group
    • 3 February 2026 · Agomab Therapeutics – building a company focused on treating fibrosis archived page
    • 24 April 2026 · Agomab Therapeutics – building a company focused on treating fibrosis archived page
    • 12 July 2026 · Agomab Therapeutics – building a company focused on treating fibrosis archived page
    • 8 October 2026 · Agomab Therapeutics – building a company focused on treating fibrosis archived page
    • 4 November 2026 · Agomab Therapeutics – building a company focused on treating fibrosis current websiteHistorical capture not publicly available
    • 6 November 2026 · Agomab Therapeutics – building a company focused on treating fibrosis current websiteHistorical capture not publicly available
  2. March 2021 – July 2025 · 7 capturesAgomab Therapeutics – Restoring Organ Function

    This wording observed 8 July 2025.

    archived page
    Inspect 7 captures in this group
    • 11 March 2021 · AgomAb Therapeutics – Restoring Organ Function archived page
    • 12 January 2022 · AgomAb Therapeutics – Restoring Organ Function archived page
    • 13 July 2022 · AgomAb Therapeutics – Restoring Organ Function archived page
    • 26 September 2023 · Agomab Therapeutics – Restoring Organ Function archived page
    • 4 January 2024 · Agomab Therapeutics – Restoring Organ Function archived page
    • 8 January 2025 · Agomab Therapeutics – Restoring Organ Function archived page
    • 8 July 2025 · Agomab Therapeutics – Restoring Organ Function archived page
Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Agomab Therapeutics updates homepage focus and leadership messaging

Agomab Therapeutics revised its homepage headline to emphasize a focus on treating fibrosis and highlighted leadership experience tied to a substantial equity raise at another company, and it added a careers page.

  • Between July 2025 and February 2026, Agomab Therapeutics changed its homepage headline from “Agomab Therapeutics – Restoring Organ Function” to “Agomab Therapeutics – building a company focused on treating fibrosis”. [3]
  • Between January 2024 and January 2025, Agomab Therapeutics’ homepage stated: “Under his leadership, CureVac raised over $1.6 billion in equity.” [2]
  • Between August 2020 and March 2021, Agomab Therapeutics added a careers page. [1]
  • Reading: The fibrosis-focused homepage headline between July 2025 and February 2026 suggests Agomab Therapeutics may be emphasizing fibrosis as a central theme of its positioning. [3]

Cite this record

StartupHistory, “Agomab Therapeutics” company record, https://startuphistory.org/c/agomab.com

Machine-readable: /c/agomab.com.json. How changes are found: method.